HR 124 United States House · 119th Congress

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

This bill amends Medicaid rules to require education about renal medullary carcinoma (a rare kidney cancer) for individuals with Sickle Cell Disease. It adds "renal medullary carcinoma" to the list of conditions Medicaid must cover through patient education, alongside existing topics like stroke. The change applies to services provided after the bill's enactment date. It directly affects Medicaid beneficiaries diagnosed with Sickle Cell Disease by expanding their access to targeted cancer risk education.
Sub-Topics: Medicaid
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
President
Introduced Jan 3, 2025 Last action Jan 3, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jan 3, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 3, 2025
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Al Green
Al Green
DDemocratic
TX
9